Senti Bio to Participate in Upcoming Investor Conferences
September 03, 2024 08:15 ET
|
Senti Biosciences, Inc.
Senti Bio will participate in two upcoming investor conferences in September.
CGT Research Outlook Technology Report 2024: Capacity and Capability Expansion for CDMOs, Technology Licensing Partnerships, Shift Towards CGT Development for Chronic Diseases
August 30, 2024 06:46 ET
|
Research and Markets
Dublin, Aug. 30, 2024 (GLOBE NEWSWIRE) -- The "CGT Research Outlook and Technology Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. The report covers the...
Researchers call for individualized gene therapies to be more widely accessible
August 29, 2024 07:25 ET
|
MIT Sloan School of Management
Cambridge, MA, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Cambridge, MA, August 29, 2024 – As gene and cell therapy and gene editing technologies continue to revolutionize the treatment of genetic diseases,...
NurExone Reports Second Quarter 2024 Financial Results and Provides Corporate Update
August 28, 2024 08:34 ET
|
NurExone Biologic Inc
NurExone Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Vor Bio to Participate in Upcoming Investor Conferences
August 28, 2024 08:00 ET
|
Vor Biopharma
CAMBRIDGE, Mass., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming...
KSQ Therapeutics to Participate in Upcoming Investor Conferences
August 28, 2024 07:00 ET
|
KSQ
KSQ Therapeutics to Participate in Upcoming Investor Conferences
Longeveron to Present at the H.C. Wainwright 26th Annual Global Investment Conference
August 26, 2024 16:05 ET
|
Longeveron
Longeveron to present at HC Wainwright global investment conference.
NurExone Biologic Invited to Present Groundbreaking ExoPTEN Therapy at Prestigious September Conferences
August 23, 2024 16:03 ET
|
NurExone Biologic Inc
NurExone Biologic to present its innovative ExoPTEN therapy at key September conferences in Boston and New York, showcasing its leadership in regenerative
Abata Therapeutics Receives FDA Fast Track Designation for ABA-101 for the Treatment of Progressive Multiple Sclerosis
August 22, 2024 07:00 ET
|
Abata
Abata Therapeutics Receives FDA Fast Track Designation for ABA-101 for the Treatment of Progressive Multiple Sclerosis
American Institutes for Research To Help Implement Federal Program Aimed at Increasing Access to Transformative Cell and Gene Therapy Treatments
August 21, 2024 12:00 ET
|
American Institutes for Research
Arlington, Va., Aug. 21, 2024 (GLOBE NEWSWIRE) -- The American Institutes for Research (AIR) has been awarded a federal contract to help implement and monitor a new program that seeks to make...